Project Grant R01AG086441

Award Date 5/15/24
Completion Date 4/30/29
Dollars Obligated $2.6M
Federal Grant Program
93.866
Assistance Type
Project Grant
Place of Performance
Irvine, CA 92697, USA
Similar Awards
This Project Grant award, provided by the National Institute on Aging (NIA) under the Aging Research program (CFDA 93.866), aims to investigate the mechanisms underlying neuronal hyperexcitability in the entorhinal cortex (EC) of Alzheimer's disease (AD) mouse models. The $1,758,779 award, effective August 1, 2024 through July 31, 2026, will support studies to determine whether hyperexcitability is due to dysfunction of excitatory or inhibitory neurons in the EC. The research will use...
This three-year, $3,027,312 Project Grant from the National Institute on Aging, part of the Department of Health and Human Services, will fund research into the role of hippocampal inhibitory interneurons in novel memory formation and how this process is disrupted in Alzheimer's disease. Specifically, the awardee, Georgia Tech Research Corporation, will record electrical activity from inhibitory and excitatory neurons in mice and selectively stimulate parvalbumin-positive interneurons to test...
This federal Project Grant award of $307,000.00 from the National Institute on Aging (CFDA 93.866 - Aging Research) aims to conduct a single, highly powered study to identify memory processes that are most sensitive to the asymptomatic, preclinical stage of Alzheimer's disease (AD) pathology. The study combines a continuous report item-location associative memory task with advanced behavioral and neural modeling to estimate subtle changes in memory precision that may differentiate healthy...
This Project Grant award from the National Institute on Aging (CFDA 93.866 Aging Research) aims to advance understanding of inhibitory interneuron dysfunction and its contribution to neural circuit dysregulation in Alzheimer's disease (AD) and related dementias. The $338,527 award, effective August 15, 2024 through May 31, 2029, will support the following key activities: Identifying disrupted interneuron gene expression patterns in post-mortem AD brain samples using spatial transcriptomic...
The National Institute on Aging (NIA) awarded a $454,024 Project Grant (CFDA 93.866 - Aging Research) to the Research Foundation For Mental Hygiene, Inc. (RFMH) to conduct research on high-frequency oscillations (HFOs) as a potential biomarker for Alzheimer's disease progression. The key goals of this 2-year project are to: (1) determine if HFOs originate in the hippocampus and expand to other brain regions as Alzheimer's pathology advances, (2) assess whether disrupting HFOs can improve...
This Project Grant award of $2,683,965.00 from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program will fund the development and optimization of an "all-human cellular system" for studying Alzheimer's disease (AD) and age-related dementias (ADRDs). The primary objectives are to: 1) define delivery conditions for introducing patient blood cells and plasma into a...
This Project Grant award from the National Institute on Aging (NIA) under the Aging Research program (CFDA 93.866) provides $1,853,477 to the Research Foundation for Mental Hygiene, Inc. (RFMH) at the Nathan S. Kline Institute to conduct research on hyperexcitability and interictal spike activity in Alzheimer's disease. The research aims to investigate the origins and mechanisms of these neural phenomena, as well as evaluate whether selectively inhibiting them can improve cognition and reduce...
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $454,271 to Florida Atlantic University to investigate the role of amyloid precursor protein (APP) and cholesterol homeostasis in synaptic dysfunction and neurodegeneration related to Alzheimer's disease (AD). The research aims to use human neurons derived from induced pluripotent stem cells (hiNs) to systematically study how mutations affecting APP distribution, trafficking, and interaction...
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) will support research to investigate memory reactivation during sleep in a mouse model of Alzheimer's disease (AD). The $132,705 award, spanning from September 1, 2024 to August 31, 2026, will enable the Icahn School of Medicine at Mount Sinai to use two-photon microscopy and electrophysiology to measure brain activity across wake and sleep states in AD model mice. The research aims to determine if...
This Project Grant award from the National Institute on Aging (NIA), under the Aging Research (CFDA 93.866) federal grant program, provides $622,000 to the University of Maryland, Baltimore to investigate the role of mitochondrial complex I deficiency in Alzheimer's disease (AD) and dementia. The key objectives are to: 1) Determine the effects of complex I deficiency on humanized amyloid-beta (Aβ) proteinopathy, a hallmark of AD, and 2) Assess the susceptibility of complex I-deficient mice to AD...

LATERAL ENTORHINAL CORTEX DYSFUNCTION IN AN APP KNOCK-IN MODEL OF ALZHEIMER'S DISEASE - PROJECT SUMMARY ALZHEIMER'S DISEASE (AD), THE MOST COMMON DEMENTIA, CURRENTLY AFFECTS ~6.7 MILLION INDIVIDUALS IN THE U.S. ALONE AND IS EXPECTED TO GROW TO 13 MILLION BY THE YEAR 2050. A MAJOR COMPONENT OF ITS DEVASTATION IS THE PROGRESSIVE LOSS OF THE PATIENT'S ABILITY TO FORM MEMORIES. TREATMENTS FOR RESCUING MEMORY FUNCTION IN AD PATIENTS DO NOT EXIST, DUE IN PART TO INSUFFICIENT RESEARCH PERFORMED TO CHARACTERIZE THE ACTIVITY OF MEMORY-SUPPORTING NEURAL CIRCUITS COMPROMISED BY THE DISEASE. THE EFFORT TO DEVELOP MEMORY-RESTORATIVE THERAPEUTICS THAT INTERVENE IN NEURAL CIRCUITS REQUIRES INVESTIGATION OF WHICH CIRCUIT-LEVEL FUNCTIONS ARE IMPACTED DURING PATHOPHYSIOLOGICAL PROGRESSION, AND HOW THEY RELATE TO MEMORY PERFORMANCE. NEURONS IN THE ENTORHINAL CORTEX (EC) ACT AS A GATEWAY FOR SENSORY INPUTS FEEDING INTO THE HIPPOCAMPUS. THIS EC-HIPPOCAMPUS CIRCUIT IS CRITICAL FOR MEMORY FORMATION AND RETRIEVAL. INSIDE THE EC, THE LATERAL ENTORHINAL CORTEX (LEC) IS A PRIMARY SITE OF ATROPHY AND ACTIVITY LOSS IN THE EARLY PHASES OF AD. DESPITE ITS SIGNIFICANCE TO AD PATHOPHYSIOLOGY, IT REMAINS UNCLEAR WHAT TYPE OF ACTIVITY IS LOST IN THE LEC OF AD PATIENTS OR ANIMAL MODELS. OUR LABORATORY'S PIONEERING PREVIOUS RESEARCH HAS DEVELOPED EXCITING PRELIMINARY RESULTS THAT SUGGEST A PATH FORWARD. WE HAVE FOUND IN HEALTHY RATS THAT LEC NEURONS DEVELOP REWARD-ASSOCIATED SPIKE REPRESENTATIONS DURING ASSOCIATIVE LEARNING. RECENTLY, USING OPTOGENETIC CIRCUIT ANALYSES, WE FOUND IN HEALTHY WILD TYPE (WT) MICE THAT (I) LEC LAYER 2A NEURONS CATEGORIZE REWARDED VS. UNREWARDED SENSORY CUES WHEN MICE ARE PERFORMING ASSOCIATIVE LEARNING, AND (II) THIS CATEGORIZATION ACTIVITY IS FACILITATED BY DOPAMINE INPUTS FROM THE VENTRAL TEGMENTAL AREA (VTA) TO THE LEC. OUR OVERALL HYPOTHESIS IS THAT DYSFUNCTION OF LEC NEURONAL ACTIVITY FOR MEMORY ENCODING CAUSES ASSOCIATIVE MEMORY IMPAIRMENT IN APP KNOCK- IN MICE. TO TEST THIS HYPOTHESIS, WE WILL (AIM 1) DETERMINE CELL TYPES THAT SHOW ACTIVITY DYSFUNCTION IN THE LEC, (AIM 2) DETERMINE IF DYSFUNCTION OF LEC DOPAMINE CAUSES ASSOCIATIVE MEMORY IMPAIRMENT, AND (AIM 3) DETERMINE IF LEC 20-40HZ OSCILLATION DEFICIT UNDERLIES ASSOCIATIVE MEMORY IMPAIRMENT. THE PROJECT IS EXPECTED TO YIELD ADVANCES TOWARD THE DEVELOPMENT OF THERAPEUTICS TO RESCUE MEMORY FUNCTION IN THE LEC.

Posted 5/10/24, 12:00 AM